Literature DB >> 19001410

Quantitative proteomics characterization of a mouse embryonic stem cell model of Down syndrome.

Yuqin Wang1, Claire Mulligan, Gareth Denyer, Frederic Delom, Franca Dagna-Bricarelli, Victor L J Tybulewicz, Elizabeth M C Fisher, William J Griffiths, Dean Nizetic, Jürgen Groet.   

Abstract

Down syndrome, caused by the trisomy of chromosome 21, is a complex condition characterized by a number of phenotypic features, including reduced neuron number and synaptic plasticity, early Alzheimer disease-like neurodegeneration, craniofacial dysmorphia, heart development defects, increased incidence of childhood leukemia, and powerful suppression of the incidence of most solid tumors. Mouse models replicate a number of these phenotypes. The Tc1 Down syndrome model was constructed by introducing a single supernumerary human chromosome 21 into a mouse embryonic stem cell, and it reproduces a large number of Down syndrome phenotypes including heart development defects. However, little is still known about the developmental onset of the trisomy 21-induced mechanisms behind these phenotypes or the proteins that are responsible for them. This study determined the proteomic differences that are present in undifferentiated embryonic stem cells and are caused by an additional human chromosome 21. A total of 1661 proteins were identified using two-dimensional liquid chromatography followed by tandem mass spectrometry from whole embryonic stem cell lysates. Using isobaric tags for relative and absolute quantification, we found 52 proteins that differed in expression by greater than two standard deviations from the mean when an extra human chromosome 21 was present. Of these, at least 11 have a possible functional association with a Down syndrome phenotype or a human chromosome 21-encoded gene. This study also showed that quantitative protein expression differences in embryonic stem cells can persist to adult mouse as well as reproduce in human Down syndrome fetal tissue. This indicates that changes that are determined in embryonic stem cells of Down syndrome could potentially identify proteins that are involved in phenotypes of Down syndrome, and it shows that these cell lines can be used for the purpose of studying these pathomechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19001410      PMCID: PMC2667343          DOI: 10.1074/mcp.M800256-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  39 in total

1.  Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.

Authors:  J T Richtsmeier; L L Baxter; R H Reeves
Journal:  Dev Dyn       Date:  2000-02       Impact factor: 3.780

2.  The SCFCdc4 ubiquitin ligase regulates calcineurin signaling through degradation of phosphorylated Rcn1, an inhibitor of calcineurin.

Authors:  Tsutomu Kishi; Akemi Ikeda; Rina Nagao; Noriko Koyama
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

3.  Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.

Authors:  L L Baxter; T H Moran; J T Richtsmeier; J Troncoso; R H Reeves
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

Review 4.  To err (meiotically) is human: the genesis of human aneuploidy.

Authors:  T Hassold; P Hunt
Journal:  Nat Rev Genet       Date:  2001-04       Impact factor: 53.242

Review 5.  GLUT1 deficiency syndrome--2007 update.

Authors:  Joerg Klepper; Baerbel Leiendecker
Journal:  Dev Med Child Neurol       Date:  2007-09       Impact factor: 5.449

6.  The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome.

Authors:  Yuqin Wang; Sabina Muneton; Jan Sjövall; Jasmina N Jovanovic; William J Griffiths
Journal:  J Proteome Res       Date:  2008-02-28       Impact factor: 4.466

7.  DYRK1A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic stem cell fate in Down syndrome.

Authors:  Claudia Canzonetta; Claire Mulligan; Samuel Deutsch; Sandra Ruf; Aideen O'Doherty; Robert Lyle; Christelle Borel; Nathalie Lin-Marq; Frederic Delom; Jürgen Groet; Felix Schnappauf; Serena De Vita; Sharon Averill; John V Priestley; Joanne E Martin; Janet Shipley; Gareth Denyer; Charles J Epstein; Cristina Fillat; Xavier Estivill; Victor L J Tybulewicz; Elizabeth M C Fisher; Stylianos E Antonarakis; Dean Nizetic
Journal:  Am J Hum Genet       Date:  2008-09-04       Impact factor: 11.025

8.  Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins.

Authors:  Johannes Graumann; Nina C Hubner; Jeong Beom Kim; Kinarm Ko; Markus Moser; Chanchal Kumar; Jürgen Cox; Hans Schöler; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2007-11-28       Impact factor: 5.911

9.  KEGG for linking genomes to life and the environment.

Authors:  Minoru Kanehisa; Michihiro Araki; Susumu Goto; Masahiro Hattori; Mika Hirakawa; Masumi Itoh; Toshiaki Katayama; Shuichi Kawashima; Shujiro Okuda; Toshiaki Tokimatsu; Yoshihiro Yamanishi
Journal:  Nucleic Acids Res       Date:  2007-12-12       Impact factor: 16.971

10.  An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model.

Authors:  Afua Mensah; Claire Mulligan; Jackie Linehan; Sandra Ruf; Aideen O'Doherty; Beata Grygalewicz; Janet Shipley; Juergen Groet; Victor Tybulewicz; Elizabeth Fisher; Sebastian Brandner; Dean Nizetic
Journal:  BMC Dev Biol       Date:  2007-11-29       Impact factor: 1.978

View more
  9 in total

Review 1.  Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biology.

Authors:  Rebekah L Gundry; Paul W Burridge; Kenneth R Boheler
Journal:  Proteomics       Date:  2011-09-08       Impact factor: 3.984

Review 2.  Toward a complete in silico, multi-layered embryonic stem cell regulatory network.

Authors:  Huilei Xu; Christoph Schaniel; Ihor R Lemischka; Avi Ma'ayan
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010 Nov-Dec

Review 3.  Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.

Authors:  Eugenio Barone; Andrea Arena; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2017-07-10       Impact factor: 7.376

Review 4.  Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.

Authors:  Marzia Perluigi; Fabio Di Domenico; D Allan Buttterfield
Journal:  Proteomics Clin Appl       Date:  2014-02       Impact factor: 3.494

5.  Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.

Authors:  S De Vita; C Canzonetta; C Mulligan; F Delom; J Groet; C Baldo; L Vanes; F Dagna-Bricarelli; A Hoischen; J Veltman; E M C Fisher; V L J Tybulewicz; D Nizetic
Journal:  Oncogene       Date:  2010-08-09       Impact factor: 9.867

6.  What can we learn from study of Alzheimer's disease in patients with Down syndrome for early-onset Alzheimer's disease in the general population?

Authors:  Robyn A Wallace; Arthur J Dalton
Journal:  Alzheimers Res Ther       Date:  2011-04-19       Impact factor: 6.982

7.  Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.

Authors:  Aoife Murray; Audrey Letourneau; Claudia Canzonetta; Elisavet Stathaki; Stefania Gimelli; Frederique Sloan-Bena; Robert Abrehart; Pollyanna Goh; Shuhui Lim; Chiara Baldo; Franca Dagna-Bricarelli; Saad Hannan; Martin Mortensen; David Ballard; Denise Syndercombe Court; Noemi Fusaki; Mamoru Hasegawa; Trevor G Smart; Cleo Bishop; Stylianos E Antonarakis; Jürgen Groet; Dean Nizetic
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

8.  DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment.

Authors:  Ilario De Toma; Mireia Ortega; Patrick Aloy; Eduard Sabidó; Mara Dierssen
Journal:  Front Mol Neurosci       Date:  2019-11-15       Impact factor: 5.639

9.  Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain.

Authors:  Md Mahiuddin Ahmed; A Ranjitha Dhanasekaran; Suhong Tong; Frances K Wiseman; Elizabeth M C Fisher; Victor L J Tybulewicz; Katheleen J Gardiner
Journal:  Hum Mol Genet       Date:  2013-01-24       Impact factor: 6.150

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.